Dermatology Medical News about Pemphigus

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Treatment of pemphigus vulgaris and pemphigus foliaceus
Expert Review of Dermatology, 10/13/09

Sebaratnam D et al. – Pemphigus is a rare autoimmune bullous disease, and the best evidence–based approach to the management of this dermatosis is still a contentious issue. Therapeutic approaches must recognize the chronic, relapsing and remitting nature of the disease and that morbidity is mainly a result of treatment. Corticosteroids are the cornerstone of treatment; however, adjuvant therapies, such as azathioprine, mycophenolate mofetil, cyclophosphamide, and newer therapies, such as plasmapheresis, intravenous immunoglobulin and rituximab, are being increasingly utilized.

<< Previous
Ustekinumab for the treatment of plaque psoriasis

Next >>
An epidemic of furniture-related dermatitis: searching for a...

Subcorneal Pustular Dermatosis-Type IgA Pemphigus With Autoantibodies to Desmocollins 1, 2, and 3
Archives of Dermatology, 10/22/09 Relevance Score: 88%

Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype
Clinical and Experimental Dermatology, 11/10/09 Relevance Score: 85%

Demonstration of pemphigus-specific immunofluorescence pattern by direct immunofluorescence of plucked hair
International Journal of Dermatology, 10/28/09 Relevance Score: 85%

Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid: Analysis of Current Data
American Journal of Clinical Dermatology, 10/20/09 Relevance Score: 85%

Simultaneous occurrence of anti-BP180 mucous membrane pemphigoid and mucosal-dominant pemphigus vulgaris
Clinical and Experimental Dermatology, 10/08/09 Relevance Score: 84%